WHO recommendations on antenatal care for a positive pregnancy experience

<strong>WHO</strong> <strong>recommendations</strong> on antenatal care for a positive pregnancy experience
74. Joint Formulary Committee. Vitamin deficiency.
Chapter 9: Blood and Nutrition. In: British
National Formulary (BNF) 72. London: BMJ
Publishing Group Ltd and Royal Pharmaceutical
Society; 2016.
75. Guideline: Vitamin D supplementation in
pregnant women. Geneva: World Health
Organization; 2012 (http://apps.who.int/iris/
bitstream/10665/85313/1/9789241504935_
eng.pdf, accessed 4 October 2016).
76. De-Regil LM, Palacios C, Lombardo LK, Peña-
Rosas JP. Vitamin D supplementation for women
during pregnancy. Cochrane Database Syst Rev.
2016;(1):CD008873.
77. Chen LW, Wu Y, Neelakantan N, Chong MF,
Pan A, van Dam RM. Maternal caffeine intake
during pregnancy is associated with risk of low
birth weight: a systematic review and doseresponse
meta-analysis. BMC Med. 2014;12:174.
doi:10.1186/s12916-014-0174-6.
78. Rhee J, Kim R, Kim Y, Tam M, Lai Y, Keum N,
Oldenburg CE. Maternal caffeine consumption
during pregnancy and risk of low birth weight: a
dose-response meta-analysis of observational
studies. PLoS One. 2015;10(7):e0132334.
doi:10.1371/journal.pone.0132334.
79. Chen LW, Wu Y, Neelakantan N, Chong MF,
Pan A, van Dam RM. Maternal caffeine intake
during pregnancy and risk of pregnancy
loss: a categorical and dose-response metaanalysis
of prospective studies. Public Health
Nutr. 2016:19(7):1233–44. doi:10.1017/
S1368980015002463.
80. Li J, Zhao H, Song JM, Zhang J, Tang YL, Xin
CM. A meta-analysis of risk of pregnancy
loss and caffeine and coffee consumption
during pregnancy. Int J Gynaecol Obstet.
2015;130(2):116-22. doi:10.1016/j.
ijgo.2015.03.033.
81. Sobhy S, Rogozinska E, Khan KS. Accuracy of onsite
tests to detect anaemia in antenatal care: a
systematic review. BJOG. 2016 (in press).
82. Medina Lara A, Mundy C, Kandulu J,
Chisuwo L, Bates I. Evaluation and costs of
different haemoglobin methods for use in
district hospitals in Malawi. J Clin Pathol.
2005;58(1):56–60.
83. Smaill FM, Vazquez JC. Antibiotics
for asymptomatic bacteriuria in
pregnancy. Cochrane Database Syst Rev.
2015;(8):CD000490.
84. Schmiemann G, Kniehl E, Gebhardt K,
Matejczyk MM, Hummers-Pradier E.
The diagnosis of urinary tract infection: a
systematic review. Deutsches Ärzteblatt
International. 2010;107(21):361–7. doi:10.3238/
arztebl.2010.0361.
85. Global and regional estimates of violence
against women: prevalence and health effects of
intimate partner violence and non-partner sexual
violence. Geneva: World Health Organization;
2013 (http://www.who.int/reproductivehealth/
publications/violence/9789241564625/en/,
accessed 29 September 2016).
86. Responding to intimate partner violence and
sexual violence against women: <strong>WHO</strong> clinical
and policy guidelines. Geneva: World Health
Organization; 2013 (http://apps.who.int/rhl/
guidelines/9789241548595/en/, accessed
29 September 2016).
87. van den Broek NR, Ntonya C, Mhango E,
White SA. Diagnosing anaemia in pregnancy
in rural clinics: assessing the potential of the
Haemoglobin Colour Scale. Bull World Health
Organ. 1999;77(1):15–21.
88. Rogozinska E, Formina S, Zamora J, Mignini L,
Khan KS. Accuracy of on-site tests to detect
asymptomatic bacteriuria in pregnancy: a
systematic review and meta-analysis. Obstet
Gynecol. 2016;128(3):495–503. doi:10.1097/
AOG.0000000000001597.
89. O’Doherty L, Hegarty K, Ramsay J, Davidson LL,
Feder G, Taft A. Screening women for intimate
partner violence in healthcare settings. Cochrane
Database Syst Rev. 2015;(7):CD007007.
90. Jahanfar S, Howard LM, Medley N. Interventions
for preventing or reducing domestic violence
against pregnant women. Cochrane Database
Syst Rev. 2014;(11):CD009414.
128